Opioid and Drug Abuse Commission

The Opioid and Drug Abuse Commission was a commission that advised the Trump administration on combating the ongoing opioid epidemic claiming more than 30,000 American fatalities annually in the United States.[2] The commission was chaired by New Jersey Governor Chris Christie.[3] The commission disbanded in December 2017.

Opioid and Drug Abuse Commission
Agency overview
FormedMarch 29, 2017 (2017-03-29)
DissolvedDecember 2017
JurisdictionU.S. Government
Agency executive
Parent agencyOffice of National Drug Control Policy
Key document
  • Presidential Executive Order Establishing the President’s Commission on Combating Drug Addiction and the Opioid Crisis
WebsiteExecutive Order 13784 (Archived)
Fentanyl. 2 mg (white powder to the right) is a lethal dose in most people.[1] US penny is 19 mm (0.75 in) wide.

Commission members

Mission

According to a draft of its executive order of creation, the panel was charged with responsibilities to:[5]

The commission's interim recommendations were slated to be due within 90 days of its inauguration and a final report, in October 2017. The final report is: The President's Commission on Combatting Drug Addiction and the Opiod Crisis - final report

See also

References

  1. Fentanyl. Image 4 of 17. US DEA (Drug Enforcement Administration). See archive with caption: "photo illustration of 2 milligrams of fentanyl, a lethal dose in most people".
  2. The Editorial Board (February 3, 2018). "Opinion - How Trump Can Keep His Vows on Opioids and Infrastructure". The New York Times. Retrieved January 13, 2019.
  3. Williams, Weston (March 29, 2017). "To address opioid crisis, Trump to give Chris Christie the helm". Christian Science Monitor. Retrieved July 4, 2017.
  4. THE PRESIDENT’S COMMISSION ON COMBATING DRUG ADDICTION AND THE OPIOID CRISIS
  5. Says, Joe Dupont (March 28, 2017). "Executive order lays out blueprint for Trump opioid commission". STAT. Retrieved July 4, 2017.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.